FDA approves fibryga for acquired fibrinogen deficiency, potentially ushering in a new standard of care – OctaPharma
Octapharma USA, Inc. has announced the expanded approval of fibryga, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in bleeding patients with acquired fibrinogen deficiency (AFD) by… read more.
